Skip to content

Developing Optimal Focal Muscle Vibration for Improving Spasticity

Optimization of Physical Focal Stimulation Parameters for Improving Spasticity and Identification of Neurophysiological Mechanism

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01915342
Enrollment
17
Registered
2013-08-02
Start date
2013-08-31
Completion date
2014-09-30
Last updated
2014-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Electrophysiology, Muscle Spasticity, Vibration

Keywords

Monosynaptic reflex, H-reflex

Brief summary

The overall aim of the proposed study is to determine optimal parameter of focal muscle vibration for improving spasticity and identify neurophysiological mechanism in healthy subjects. In investigation I-1, subjects will undergo focal muscle vibration with 40, 80, 120 Hz frequency at the medial gastrocnemius muscles (mGCM). As a surrogate maker of spasticity, H-reflex and compound motor action potential (CMAP) of the tibial nerve at mGCM will be recorded pre, during, and post vibration. In investigation I-2, subjects will undergo focal muscle vibration with 0.1, 0.3, 0.5 mm amplitude at mGCM. H-reflex and CMAP of the tibial nerve at mGCM will be recorded pre, during, and post vibration. In investigation II, subjects will undergo focal muscle vibration with predetermined parameters by the investigation I at mGCM. H-reflex and CMAP of the tibial nerve and motor evoked potential at mGCM will be recorded pre, during, and post vibration.

Interventions

DEVICEFocal muscular vibration

Sponsors

Korea Institute of Science and Technology
CollaboratorOTHER
Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Healthy volunteer

Exclusion criteria

* Unstable medical conditions * History of epilepsy * History of drug abuse

Design outcomes

Primary

MeasureTime frameDescription
H/M ratiobaseline, 1, 5 and 10 minutes during vibration, and 1 and 5 minutes after vibrationThe ratio of maximal H-reflex amplitude (mV) to CMAP amplitude (mV) recorded at mGCM

Secondary

MeasureTime frameDescription
M amplitudebaseline, 1, 5 and 10 minutes during vibration, and 1 and 5 minutes after vibrationCMAP amplitude (mV) recorded at mGCM
motor evoked potential (MEP) amplitudebaseline, 10 minutes during vibration, and 5 minutes after vibrationTranscranial magnetic stimulation on the contralateral leg motor cortex is used to measure MEP at mGCM.
H amplitudebaseline, 1, 5 and 10 minutes during vibration, and 1 and 5 minutes after vibrationmaximal H-reflex amplitude (mV) recorded at mGCM
Short interval intracortical inhibitionbaseline, 10 minutes during vibration, and 5 minutes after vibrationShort interval intracortical inhibition is recorded by using conditioning stimulus of 90% RMT and test stimulus of 120% RMT with 1ms interval.
Intracortical facilitationbaseline, 10 minutes during vibration, and 5 minutes after vibrationIntracortical facilitation is recorded by using conditioning stimulus of 90% RMT and test stimulus of 120% RMT with 10ms interval.
Resting motor threshold (RMT)baseline, 10 minutes during vibration, and 5 minutes after vibrationResting motor threshold (%) is defined as the minimal intensity of TMS capable of inducing MEPs greater than 100μV peak-to-peak amplitude in at least 3 of 5 trials.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026